Sponsored by:
Melissa Juried Kriebel
IceCream Sunscreen
IceCreamSunscreen
Other hedge funds have also made changes to their positions in the company. Gladius Capital Management LP grew its position in shares of Nu Skin Enterprises by 18.2% during the first quarter. Gladius Capital Management LP now owns 2,278 shares of the company’s stock worth $110,000 after buying an additional 351 shares in the last quarter. Dupont Capital Management Corp grew its position in shares of Nu Skin Enterprises by 23.5% during the first quarter. Dupont Capital Management Corp now owns 3,893 shares of the company’s stock worth $186,000 after buying an additional 742 shares in the last quarter. FORA Capital LLC acquired a new stake in shares of Nu Skin Enterprises during the first quarter worth approximately $201,000. Profund Advisors LLC acquired a new stake in shares of Nu Skin Enterprises during the first quarter worth approximately $210,000. Finally, Meritage Portfolio Management grew its position in shares of Nu Skin Enterprises by 11.4% during the first quarter. Meritage Portfolio Management now owns 4,803 shares of the company’s stock worth $230,000 after buying an additional 492 shares in the last quarter. Institutional investors and hedge funds own 88.20% of the company’s stock.
Analyst Ratings Changes
A number of research firms have recently weighed in on NUS. TheStreet downgraded shares of Nu Skin Enterprises from a “b” rating to a “c” rating in a research report on Thursday, August 4th. Citigroup decreased their price target on shares of Nu Skin Enterprises from $47.00 to $39.00 and set a “neutral” rating for the company in a research report on Wednesday, October 5th. StockNews.com cut Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Thursday. Finally, DA Davidson reduced their price objective on Nu Skin Enterprises from $45.00 to $40.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 23rd.
Nu Skin Enterprises Stock Performance
Shares of NUS opened at $40.16 on Friday. The business’s fifty day moving average price is $37.98 and its 200 day moving average price is $42.52. Nu Skin Enterprises, Inc. has a 12-month low of $33.29 and a 12-month high of $56.76. The stock has a market capitalization of $2.02 billion, a PE ratio of 18.09 and a beta of 1.20. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.30 and a quick ratio of 1.38.
Nu Skin Enterprises (NYSE:NUS – Get Rating) last posted its earnings results on Thursday, August 4th. The company reported $0.77 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.79 by ($0.02). The company had revenue of $560.62 million during the quarter, compared to the consensus estimate of $559.91 million. Nu Skin Enterprises had a net margin of 4.57% and a return on equity of 19.78%. Equities research analysts forecast that Nu Skin Enterprises, Inc. will post 3.34 EPS for the current year.
Nu Skin Enterprises Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Wednesday, September 7th. Shareholders of record on Friday, August 26th were paid a $0.385 dividend. This represents a $1.54 dividend on an annualized basis and a yield of 3.83%. The ex-dividend date was Thursday, August 25th. Nu Skin Enterprises’s payout ratio is 69.37%.
Insider Buying and Selling at Nu Skin Enterprises
In other Nu Skin Enterprises news, Director Andrew D. Lipman sold 1,000 shares of the firm’s stock in a transaction on Friday, October 21st. The stock was sold at an average price of $35.92, for a total value of $35,920.00. Following the sale, the director now directly owns 68,393 shares in the company, valued at $2,456,676.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Nu Skin Enterprises news, CAO James D. Thomas sold 1,602 shares of the firm’s stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $39.19, for a total value of $62,782.38. Following the sale, the chief accounting officer now directly owns 12,722 shares in the company, valued at $498,575.18. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Andrew D. Lipman sold 1,000 shares of the firm’s stock in a transaction on Friday, October 21st. The shares were sold at an average price of $35.92, for a total value of $35,920.00. Following the transaction, the director now directly owns 68,393 shares in the company, valued at $2,456,676.56. The disclosure for this sale can be found here. Over the last three months, insiders have sold 29,602 shares of company stock worth $1,255,132. 2.80% of the stock is owned by insiders.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.
Recommended Stories
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS – Get Rating).
Receive News & Ratings for Nu Skin Enterprises Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Nu Skin Enterprises and related companies with MarketBeat.com’s FREE daily email newsletter.